People

Emilė Radytė

samphireneuro.com

Emilė Radytė is published by Samphire Neuroscience as Emilė Radytė PhD CEO (Founder). This role is part of its current core leadership and research team developing non-invasive neurotechnology for menstrual-health symptoms. Co-founder with a neuroscience PhD; UKRI identifies Emile Radyte as project manager for the company’s clinical and device research. Primary investor AfterWork’s January2022 thesis describes her Oxford doctorate research in neurobiology/neuroscience, modelling deep-brain stimulation for psychiatric applications and neurocognitive biomarkers of response in depression. She previously studied neuroscience and social anthropology at Harvard, graduating summa cum laude; the current company directory confirms her completed PhD and co-founder/CEO role. The company’s own clinician-training page identifies Oxford and Harvard training. Her device company commercialises non-invasive stimulation; prior deep-brain research does not mean its product is an implanted device.